Log In Sign up
The largest database of trusted experimental protocols

Mir 338 3p inhibitor

Manufactured by RiboBio
Visit Supplier
Sourced in China

The MiR-338-3p inhibitor is a laboratory product designed to inhibit the expression of the miR-338-3p microRNA. It can be used as a research tool to study the biological functions and regulatory mechanisms of miR-338-3p in various cellular and molecular processes.

Automatically generated - may contain errors

Lab products found in correlation

Mir 338 3p mimic, by RiboBio (3 mentions) Lipofectamine 2000, by Thermo Fisher Scientific (2 mentions) Mir 205 mimic, by RiboBio (1 mentions) Mir 205 inhibitor, by RiboBio (1 mentions) Mirna inhibitor nc, by RiboBio (1 mentions) Mirna mimic nc, by RiboBio (1 mentions) Mir control, by RiboBio (1 mentions)

3 protocols using mir 338 3p inhibitor

1

Transfection of miR-205 and miR-338-3p

Check if the same lab product or an alternative is used in the 5 most similar protocols
The miR-205 mimics, miR-205 inhibitor, miR-338-3p mimics, and miR-338-3p inhibitor and the negative control were all purchased from Guangzhou RiboBio Co., Ltd. (Guangzhou, China). The cells were transfected using 100 nm Lipofectamine 2000 (Invitrogen Inc., Carlsbad, CA, USA) following the manufacturer’s instructions.
Zhang X., Pan Y., Fu H, & Zhang J. (2019). microRNA-205 and microRNA-338-3p Reduces Cell Apoptosis in Prostate Carcinoma Tissue and LNCaP Prostate Carcinoma Cells by Directly Targeting the B-Cell Lymphoma 2 (Bcl-2) Gene. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research, 25, 1122-1132.
+ Open protocol
+ Expand
2

MicroRNA Mimic and Inhibitor Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The miR-338-3p mimic, miR-338-3p inhibitor, miRNA mimic NC, and miRNA inhibitor NC were purchased from RiboBio (Guangzhou, China). Transfection was carried out using according to the manufacturer’s instructions.
Zhen S., Jia Y., Zhao Y., Wang J., Zheng B., Liu T., Duan Y., Lv W., Wang J., Xu F., Liu Y., Zhang Y, & Liu L. (2024). NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence. Cell Death Discovery, 10, 131.
+ Open protocol
+ Expand
3

miR-338-3p Regulation in Renal Cell Carcinoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
RCC cells were seeded into the 6-well plate and were respectively transfected with 5nM miR-338-3p inhibitor, miR-338-3p mimic or miR-control. The Caki-1 and 786-O cells were transfected with Lipofectamine 2000 (Invitrogen). miR-338-3p inhibitor (5′-GCAAAAAUUAGUGUGCGCCAAA-3′), miR-338-3p mimic (5′-UUUGAGCAGCACUCAUUUUUGC-3′) and miR-control (5′-CAGUAC UUUUAGUGUGUACAA-3′) were purchased from RiboBio (Guangzhou, China), the sequence of miR-negative control was heterogenous from any known human genome sequence so as to eliminate the potential non-sequence-specific effect.
Zhang X., Wang C., Li H., Niu X., Liu X., Pei D., Guo X., Xu X, & Li Y. (2017). miR-338-3p inhibits the invasion of renal cell carcinoma by downregulation of ALK5. Oncotarget, 8(38), 64106-64113.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!